Sarepta Therapeutics, Inc. Quarterly Quick Ratio in % from Q2 2017 to Q4 2024

Taxonomy & unit
ratio: %
Description
The acid-test ratio, also called the quick ratio, is a metric used to see if a company is positioned to sell assets within 90 days to meet immediate expenses.
Summary
Sarepta Therapeutics, Inc. quarterly Quick Ratio history and growth rate from Q2 2017 to Q4 2024.
  • Sarepta Therapeutics, Inc. Quick Ratio for the quarter ending December 31, 2024 was 79.7 %, a 71.2% increase year-over-year.
Quick Ratio, Quarterly (%)
Quick Ratio, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date
Q4 2024 79.7 +33.2 +71.2% Dec 31, 2024
Q3 2024 66 +24.3 +58.3% Sep 30, 2024
Q2 2024 59.4 +21.5 +56.9% Jun 30, 2024
Q1 2024 52.8 +16.5 +45.5% Mar 31, 2024
Q4 2023 46.6 +9.13 +24.4% Dec 31, 2023
Q3 2023 41.7 +2.06 +5.2% Sep 30, 2023
Q2 2023 37.9 -10.4 -21.6% Jun 30, 2023
Q1 2023 36.3 -19 -34.3% Mar 31, 2023
Q4 2022 37.4 -23.4 -38.5% Dec 31, 2022
Q3 2022 39.6 -25.6 -39.2% Sep 30, 2022
Q2 2022 48.3 -12.4 -20.4% Jun 30, 2022
Q1 2022 55.2 -2.36 -4.1% Mar 31, 2022
Q4 2021 60.9 +5.59 +10.1% Dec 31, 2021
Q3 2021 65.2 +8.13 +14.2% Sep 30, 2021
Q2 2021 60.7 +0.2 +0.33% Jun 30, 2021
Q1 2021 57.6 -12.7 -18.1% Mar 31, 2021
Q4 2020 55.3 -26.1 -32.1% Dec 31, 2020
Q3 2020 57.1 -28.4 -33.2% Sep 30, 2020
Q2 2020 60.5 -31.2 -34% Jun 30, 2020
Q1 2020 70.3 -21.3 -23.3% Mar 31, 2020
Q4 2019 81.4 -10.5 -11.5% Dec 31, 2019
Q3 2019 85.5 -15.6 -15.5% Sep 30, 2019
Q2 2019 91.6 -7.57 -7.63% Jun 30, 2019
Q1 2019 91.7 +0.04 +0.04% Mar 31, 2019
Q4 2018 91.9 +18.3 +24.8% Dec 31, 2018
Q3 2018 101 +48.8 +93.4% Sep 30, 2018
Q2 2018 99.2 +67.9 +217% Jun 30, 2018
Q1 2018 91.6 Mar 31, 2018
Q4 2017 73.7 Dec 31, 2017
Q3 2017 52.3 Sep 30, 2017
Q2 2017 31.3 Jun 30, 2017
* An asterisk sign (*) next to the value indicates that the value is likely invalid.